Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shattuck Labs, Inc.

Clinical trials sponsored by Shattuck Labs, Inc., explained in plain language.

Shattuck Labs, Inc. STTK NASDAQ

A clinical-stage biotech developing immunotherapies for cancer.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1 Not yet finished but already full! 1 Completed 1 Terminated 1

Experimental combo for MDS and AML shows early promise but trial halted

Disease control Terminated

This early-phase trial tested an experimental drug called SL-172154, given alongside standard chemotherapy drugs, for people with higher-risk myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). The main goals were to check safety and find the right dose. The study was…

Phase: PHASE1 • Sponsor: Shattuck Labs, Inc. • Aim: Disease control

Last updated Jun 27, 2026 11:02 UTC